Eosinopenia in Severe COPD Exacerbation

Recruiting Observational Study
Chronic Obstructive Pulmonary Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
35 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Northumbria Healthcare NHS Foundation Trust · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goals of this observational study are to identify factors independently associated with admission eosinopenia in patients with a severe exacerbation of chronic obstructive pulmonary disease (COPD) and to determine when blood eosinophil count (BEC) will recover to baseline stable state in patients who are admitted to hospital with a severe exacerbation of COPD and associated eosinopenia. The m…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Admitted to hospital with primary clinical diagnosis of exacerbation of COPD\* * Smoking history of at least 10 pack years * Airflow obstruction: FEV1/FVC ratio \< 0.7 confirmed on historic or inpatient spirometry * Capacity to give informed consent to participate Exclusion C…
Contacts

Stephen Bourke, MBChB, PhD

0191 293 4351

stephen.bourke@nhct.nhs.uk

CONTACT

Peter Ireland, MBBS

peter.ireland@northumbria-healthcare.nhs.uk

CONTACT